These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10931807)

  • 21. Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy.
    Ho CY; Lever HM; DeSanctis R; Farver CF; Seidman JG; Seidman CE
    Circulation; 2000 Oct; 102(16):1950-5. PubMed ID: 11034944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis.
    Anan R; Shono H; Kisanuki A; Arima S; Nakao S; Tanaka H
    Circulation; 1998 Aug; 98(5):391-7. PubMed ID: 9714088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy.
    Fujino N; Shimizu M; Ino H; Okeie K; Yamaguchi M; Yasuda T; Kokado H; Mabuchi H
    Clin Cardiol; 2001 May; 24(5):397-402. PubMed ID: 11346248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation.
    Shimizu M; Ino H; Okeie K; Yamaguchi M; Hayashi K; Nagata M; Itoh H; Iwaki T; Oe K; Konno T; Mabuchi H
    Am Heart J; 2002 Apr; 143(4):690-5. PubMed ID: 11923807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
    Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
    J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
    Rani DS; Nallari P; Priyamvada S; Narasimhan C; Singh L; Thangaraj K
    BMC Med Genet; 2012 Aug; 13():69. PubMed ID: 22876777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
    Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations.
    Coppini R; Ho CY; Ashley E; Day S; Ferrantini C; Girolami F; Tomberli B; Bardi S; Torricelli F; Cecchi F; Mugelli A; Poggesi C; Tardiff J; Olivotto I
    J Am Coll Cardiol; 2014 Dec; 64(24):2589-2600. PubMed ID: 25524337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death.
    Azimi A; Soveizi M; Salmanipour A; Mozafarybazargany M; Ghaffari Jolfayi A; Maleki M; Kalayinia S
    ESC Heart Fail; 2024 Oct; 11(5):3180-3190. PubMed ID: 38874371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.
    Fujita E; Nakanishi T; Nishizawa T; Hagiwara N; Matsuoka R
    Heart Vessels; 2013 Nov; 28(6):785-94. PubMed ID: 23494605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
    Pasquale F; Syrris P; Kaski JP; Mogensen J; McKenna WJ; Elliott P
    Circ Cardiovasc Genet; 2012 Feb; 5(1):10-7. PubMed ID: 22144547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese.
    Kubo T; Kitaoka H; Okawa M; Matsumura Y; Hitomi N; Yamasaki N; Furuno T; Takata J; Nishinaga M; Kimura A; Doi YL
    J Am Coll Cardiol; 2005 Nov; 46(9):1737-43. PubMed ID: 16256878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.
    Varnava AM; Elliott PM; Baboonian C; Davison F; Davies MJ; McKenna WJ
    Circulation; 2001 Sep; 104(12):1380-4. PubMed ID: 11560853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.